(6 November 2014 - Brussels): EFPIA, its specialised group Vaccines Europe, and the Innovative Medicines Initiative are pleased to announce the launch of a €280 million Call for proposals for an Innovative Medicines Initiative (IMI) programme aimed to address the current Ebola crisis. The Ebola+ programme will bring together the pharmaceutical industry and researchers in a collaborative programme aimed to cover the current outbreak, as well as future needs in the space of haemorrhagic fevers.